{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:33:48Z","timestamp":1790710428306,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST110\\u20132314-B-182A-151"],"award-info":[{"award-number":["MOST110\\u20132314-B-182A-151"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014477","name":"National Health Insurance Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015674","name":"Health and Welfare Data Science Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.semarthrit.2026.153017","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:37:24Z","timestamp":1780501044000},"page":"153017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Perioperative management of biologic disease-modifying antirheumatic drugs in patients with inflammatory rheumatic diseases undergoing total joint arthroplasty: A nationwide population-based cohort study from Taiwan"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3511-7527","authenticated-orcid":false,"given":"Jui-Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hsun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chien","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chih","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10055","key":"10.1016\/j.semarthrit.2026.153017_bib0001","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153017_bib0002","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153017_bib0003","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3899\/jrheum.130617","article-title":"Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991\u20132005","volume":"41","author":"Mertelsmann-Voss","year":"2014","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153017_bib0004","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/acr.24893","article-title":"2022 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total Hip or total Knee arthroplasty","volume":"74","author":"Goodman","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153017_bib0005","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.arth.2017.05.001","article-title":"2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total Hip or total Knee arthroplasty","volume":"32","author":"Goodman","year":"2017","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0006","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-025-00522-x","article-title":"Perioperative management with DMARDs in rheumatic diseases: a scoping review of clinical guidelines","volume":"9","author":"Terrett","year":"2025","journal-title":"BMC Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153017_bib0007","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2106\/JBJS.21.00811","article-title":"The effect of perioperative biologic disease-modifying anti-rheumatic drugs on the risk of postoperative complications","volume":"104","author":"van Duren","year":"2022","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153017_bib0008","doi-asserted-by":"crossref","DOI":"10.1111\/iwj.14538","article-title":"Effect of tumour necrosis factor-\u03b1 inhibitors exposure on surgical site infections in rheumatoid arthritis patients undergoing elective orthopaedic surgery: a meta-analysis","volume":"21","author":"Liu","year":"2024","journal-title":"Int Wound J"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153017_bib0009","article-title":"Perioperative use of disease modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritis","volume":"6","author":"Ponkilainen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153017_bib0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/annrheumdis-2016-210708","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis","volume":"76","author":"Ramiro","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153017_bib0011","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/14397595.2015.1014302","article-title":"Postoperative complications in patients with rheumatoid arthritis using a biological agent: a systematic review and meta-analysis","volume":"25","author":"Ito","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152201","article-title":"Perioperative treatment with TNF inhibitors does not affect survival of total hip arthroplasty in inflammatory arthritis: a registry-based cohort study","volume":"60","author":"Di Martino","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0013","first-page":"33","article-title":"Risk factors for surgical site infection and delayed wound healing after orthopedic surgery in rheumatoid arthritis patients","volume":"11","author":"Tada","year":"2016","journal-title":"J Orthop Surg Res"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153017_bib0014","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/annrheumdis-2017-212339","article-title":"Predictors of readmission, reoperation and mortality following total hip and total knee replacement in patients with rheumatoid arthritis: a nationwide Danish cohort study","volume":"77","author":"Cordtz","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153017_bib0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12891-023-06601-9","article-title":"A systematic review and meta-analysis comparing outcomes following total knee arthroplasty for rheumatoid arthritis versus for osteoarthritis","volume":"24","author":"Qiao","year":"2023","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152061","article-title":"Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a meta-analysis and systematic review","volume":"56","author":"Zhang","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153017_bib0017","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0042-1760389","article-title":"Biologic disease-modifying antirheumatic drugs do not increase risk for prosthetic joint infection in setting of total knee arthroplasty","volume":"37","author":"Bains","year":"2024","journal-title":"J Knee Surg"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153017_bib0018","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.38231","article-title":"Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis","volume":"66","author":"Ravi","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153017_bib0019","first-page":"384","article-title":"Association between disease activity of rheumatoid arthritis and risk of complications following total hip arthroplasty: a retrospective cohort study","volume":"19","author":"Mochizuki","year":"2024","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0020","article-title":"Opposing trends in total knee and hip arthroplasties for patients with rheumatoid arthritis vs. the general population\u2014a 14-year retrospective study in Tai2wan","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153017_bib0021","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3899\/jrheum.170366","article-title":"Flares in patients with rheumatoid arthritis after total hip and total knee arthroplasty: rates, characteristics, and risk factors","volume":"45","author":"Goodman","year":"2018","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153017_bib0022","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/medicina58111629","article-title":"Increased risk of common orthopedic surgeries for patients with rheumatic diseases in Taiwan","volume":"58","author":"Hsieh","year":"2022","journal-title":"Medicina (Kaunas)."},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153017_bib0023","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/M20-1594","article-title":"Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis: a cohort study","volume":"173","author":"George","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0024","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1038\/s41598-025-94342-1","article-title":"Increased early complication rates following total hip arthroplasty in rheumatoid arthritis patients based on a Japanese nationwide medical claims database study","volume":"15","author":"Mori","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153017_bib0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0026","series-title":"National health insurance annual report 2021\u20132022","year":"2022"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153017_bib0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153017_bib0028","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/acr2.11306","article-title":"Perioperative glucocorticoids in patients with rheumatoid arthritis having total joint replacements: help or harm?","volume":"3","author":"Chukir","year":"2021","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153017_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153017_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0031","first-page":"roag007","article-title":"Long-term outcomes of total knee arthroplasty without patellar resurfacing for rheumatoid arthritis","author":"Nojiri","year":"2026","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153017_bib0032","article-title":"Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database","volume":"13","author":"Shi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1376262","article-title":"Comparisons of infection events associated with tumour necrosis factor inhibitors in patients with inflammatory arthritis: a systematic review and network meta-analysis","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153017_bib0034","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ard.2025.01.032","article-title":"Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update","volume":"84","author":"Nash","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153017_bib0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13075-025-03683-9","article-title":"Perioperative discontinuation of anti-rheumatic drugs and incidence of postoperative complications in patients with rheumatoid arthritis undergoing orthopedic surgery: a multicenter retrospective cohort study","volume":"27","author":"Ito","year":"2025","journal-title":"Arthritis Res Ther"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:59:44Z","timestamp":1785873584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0049017226001071"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153017","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative management of biologic disease-modifying antirheumatic drugs in patients with inflammatory rheumatic diseases undergoing total joint arthroplasty: A nationwide population-based cohort study from Taiwan","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153017"}}